Exela Pharm Sci Private Limited
About Exela Pharm Sci Private Limited
Data last updated:
Exela Pharm Sci Private Limited is a private limited company based in Hyderabad, Telangana, India, a subsidiary of Exela Holding Llc. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 26 May 2004 and has been in existence for over 22 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24231TG2004PTC125972. Its GSTIN is 36AABCE3320K2ZV (Telangana). The company holds 3 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹3 Cr and a paid-up capital of ₹1.93 Cr. It is led by directors including Murali Krishna Reddy Adala and Saba Nayagam Ganapathi.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 4th Floor Park Citi Plaza Road No.1 Banjara Hills, Hyderabad, Telangana, India – 500082.
As per the financials filed for FY 2025, the company reported a revenue of ₹2.34 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹19.4 Lakh (net margin 8.3%) and EBITDA of ₹21.35 Lakh (EBITDA margin 9.1%). Revenue has grown at a compounded annual rate (CAGR) of 16% over three years and 49% over five years.
Court records list 2 cases involving the company, including 2 filed by the company.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address4th Floor Park Citi Plaza Road No.1 Banjara Hills, Hyderabad, Telangana, India – 500082
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
CIN History of Exela Pharm Sci Private Limited
Exela Pharm Sci has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is U24231TG2004PTC125972, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24231TG2004PTC125972 | Current |
| U24231KA2004ULT034012 | Previous |
| U24231KA2004PTC034012 | Previous |
Business Activity of Exela Pharm Sci Private Limited
The main business activity of Exela Pharm Sci is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Auditor Details of Exela Pharm Sci Private Limited
Exela Pharm Sci Private Limited is audited by REDDY A V & CO for the financial year 2021.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| REDDY A V & CO | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Exela Pharm Sci Private Limited
Exela Pharm Sci has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Murali Krishna Reddy Adala Also directs: Vauhini Property Developers LLP, Lake Park Estates LLP, Spotlight Hotels LLP and 5 more | Director | 26 May 2004 | 22 Years 4 Months | Current |
| Saba Nayagam Ganapathi | Director | 11 Jul 2016 | 10 Years 2 Months | Current |
| Phanesh Babu Koneru | Director | 29 Sep 2005 | 21 Years 0 Months | Current |
Financials of Exela Pharm Sci Private Limited FY 2025 filings available
Exela Pharm Sci Private Limited reported revenue of ₹2.34 Cr (up 1046% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Exela Pharm Sci Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 49% over five years. EBITDA rose 114% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Exela Pharm Sci Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹21.35 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹19.4 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Exela Pharm Sci Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 9.1% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 8.3% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Exela Pharm Sci are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Exela Pharm Sci Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Exela Pharm Sci Private Limited
Exela Pharm Sci Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Exela Pharm Sci Private Limited
Employment history and EPFO contributions of people linked to Exela Pharm Sci.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Exela Pharm Sci Private Limited
Exela Pharm Sci has 3 GST registrations: 1 active and 2 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AABCE3320K2ZV | Telangana | Active | 27 Sep 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Legal Cases of Exela Pharm Sci Private Limited
Exela Pharm Sci Private Limited has 2 court cases on record: 2 filed by Exela Pharm Sci. All cases are disposed. Status as checked between 29 Sep 2026 and 01 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 2 | 0 | 0 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, BENGALURU, Karnataka | Execution petition | Filed by the company against Vatsala Industries | Disposed |
| District court, BENGALURU, Karnataka | Civil suit | Filed by the company against Vatsala Industries | Disposed |
Full case history
All 2 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit Ratings, Litigation & Regulatory Alerts for Exela Pharm Sci Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Exela Pharm Sci Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Exela Pharm Sci Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Exela Pharm Sci Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Exela Pharm Sci Private Limited
Frequently Asked Questions about Exela Pharm Sci Private Limited
Exela Pharm Sci is an active private limited company based in Hyderabad, Telangana, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 26 May 2004 (22+ years old) and is registered under CIN U24231TG2004PTC125972.
Exela Pharm Sci reported revenue of ₹2.34 Cr for FY 2025 (up 1046% YoY).
Exela Pharm Sci has 3 current directors:
- Murali Krishna Reddy Adala - Director
- Saba Nayagam Ganapathi - Director
- Phanesh Babu Koneru - Director
Exela Pharm Sci reported a net profit of ₹19.4 Lakh (net margin 8.3%) and EBITDA of ₹21.35 Lakh (EBITDA margin 9.1%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Exela Pharm Sci is 16% over three years and 49% over five years. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Exela Pharm Sci is 36AABCE3320K2ZV, registered in Telangana. The company has 3 GST registrations in all, of which 1 is active and 2 are cancelled or inactive.
The CIN (Corporate Identification Number) of Exela Pharm Sci is U24231TG2004PTC125972. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Exela Pharm Sci has 2 court cases on record: 2 filed by the company.
Exela Pharm Sci was incorporated on 26 May 2004, making it 22+ years old. It is registered with the Registrar of Companies, Hyderabad.